The DOI matches its Crossref record; 15 of the 16 references it cites were found in a registry or an index.
The QT Interval and Torsade de Pointes
Abstract
The QT interval on the electrocardiogram is the time from the onset of ventricular depolarisation (the Q wave) to completion of repolarisation (the end of the T wave). It is influenced by heart rate, autonomic factors, electrolyte levels, gender and age. Aprolonged QT interval indicates an increased risk of developing malignant ventricular tachyarrhythmias, particularly torsade de pointes. QT prolongation may be primary (inherited, familial, congenital, idiopathic) or caused by disease, drugs or toxins. Drugs that have been associated with the development of torsade de pointes include antiarrhythmic, antibacterial and psychotropic agents and antihistamines. Several of these drugs depress myocardial ion channels, particularly the rapidly activating delayed rectifier (repolarising) potassium current (I(Kr)). Overdosage of drugs that affect the delayed rectifier (repolarising) potassium currents (I(K)), or coadministration of these drugs with another medication that inhibits their metabolism (e.g. an antihistamine such as terfenadine with an antifungal agent such as ketoconazole, which inhibits the cytochrome P450 3A4 hepatic enzyme), can induce torsade de pointes. Torsade de pointes is a potentially life-threatening ventricular tachyarrhythmia and the risks of administering drugs that can induce this condition must be carefully considered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A prolonged QT interval predisposes to the development of ventricular tachyarrhythmias such as torsade de pointes and ventricular fibrillation, which could cause syncope, cardiac arrest, or SCD (Haverkamp et al., 2000;Moss, 1999;Zareba et al., 1995).”
From 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry (2017) · cites this paper as Moss, 1999
Citations
Cites
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Curran, M. E., Splawski, I., Timothy, K. W., Vincen, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,259
Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKS potassium channel
Sanguinetti, M. C., Curran, M. E., Zou, A., Shen, J., Specter, P. S., Atkinson, D. L., & Keating, M. T. (1996) · Nature · doi:10.1038/384080a0 · Cited by 1,764
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias
Wang, Q., Curran, M. E., Splawski, I., Burn, T. C., Millholland, J. M., VanRaay, T. J., Shen, J., Timothy, K. W., Vincent, G. M., de Jager, T., et al. (1996) · Nature Genetics · doi:10.1038/ng0196-17 · Cited by 1,759
Self-citationSCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
Wang, Q., Shen, J., Splawski, I., Atkinson, D., Li, Z., Robinson, J. L., Moss, A. J., Towbin, J. A., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90359-3 · Cited by 1,686
Self-citationDie Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken
FRIDERICIA, L. S. (1920) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1920.tb18266.x · Cited by 1,000
An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)
Sagie, A., Larson, M. G., Goldberg, R. J., Bengtson, J. R., & Levy, D. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90562-d · Cited by 715
Terfenadine-Ketoconazole Interaction: Pharmacokinetic and Electrocardiographic Consequences
Honig, P. K. (1993) · JAMA · doi:10.1001/jama.1993.03500120051025 · Cited by 664
Multiple Mechanisms in the Long-QT Syndrome: Current Knowledge, Gaps, and Future Directions
Roden, D. M., Lazzara, R., Rosen, M., Schwartz, P. J., Towbin, J., & Vincent, G. M. (1996) · Circulation · doi:10.1161/01.cir.94.8.1996 · Cited by 628
Sicouri, S., & Antzelevitch, C. (1991) · Circulation Research · doi:10.1161/01.res.68.6.1729 · Cited by 499
Measurement of the QT interval and the risk associated with QTc interval prolongation: A review
Moss, A. J. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90036-c · Cited by 472
Self-citation
Cited by
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death
Glassman, A. H., & Bigger, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1774 · Cited by 822
Risk of Aborted Cardiac Arrest or Sudden Cardiac Death During Adolescence in the Long-QT Syndrome
Hobbs, J. B., Peterson, D. R., Moss, A. J., McNitt, S., Zareba, W., Goldenberg, I., Qi, M., Robinson, J. L., Sauer, A. J., Ackerman, M. J., et al. (2006) · JAMA · doi:10.1001/jama.296.10.1249 · Cited by 313
Self-citationSteinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P., Balsam, P., Baranchuk, A., Cantillon, D. J., Dilaveris, P., Dubner, S. J., El-Sherif, N., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.038 · Cited by 303
HERG K+ channels: friend and foe
Vandenberg, J. I., Walker, B. D., & Campbell, T. J. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01662-x · Cited by 284
Metadata
- Authors
- Moss, A. J.
- Affiliations
- University of Rochester Medicine (US)
- Corresponding author
- Moss, Arthur J.
- ORCID
- Moss, Arthur J.
- Venue
- Drug Safety
- Published
- 1999
- Volume
- 21
- Issue
- Supplement 1
- Pages
- 5-10
- ISSN
- 0114-5916 (ISSN-L)
- OpenAlex
- W1964485001
- Cited by
- 154
- References
- 16
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 5 · 2022: 5 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 9 · 2016: 12 · 2015: 6 · 2014: 3 · 2013: 8 · 2012: 5
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Safety (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- QT interval, torsades de pointes, QT prolongation, ventricular repolarization, drug-induced arrhythmia, antiarrhythmic drugs, terfenadine, ketoconazole, drug-drug interactions, CYP3A4 inhibition, ventricular tachyarrhythmia, electrocardiogram
- MeSH terms
- Animals, Electrocardiography, Humans, Long QT Syndrome, Torsades de Pointes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The QT Interval and Torsade de Pointes. https://app.cochat.ai/papers/10.2165/00002018-199921001-00002
- The paper
- Moss, A. J. (1999). The QT Interval and Torsade de Pointes. Drug Safety. https://doi.org/10.2165/00002018-199921001-00002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.